tiprankstipranks
Trending News
More News >
Edwards Lifesciences (CH:EW)
:EW
Switzerland Market
Advertisement

Edwards Lifesciences (EW) Ratios

Compare
0 Followers

Edwards Lifesciences Ratios

CH:EW's free cash flow for Q3 2025 was $0.78. For the 2025 fiscal year, CH:EW's free cash flow was decreased by $ and operating cash flow was $0.22. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.00 3.38 3.03 3.08 3.46
Quick Ratio
3.29 2.40 2.17 2.38 2.56
Cash Ratio
1.69 0.96 0.75 0.84 1.32
Solvency Ratio
0.48 0.59 0.68 0.62 0.36
Operating Cash Flow Ratio
0.64 0.75 1.19 1.68 1.18
Short-Term Operating Cash Flow Coverage
37.94 0.00 47.77 67.93 38.76
Net Current Asset Value
$ 3.69B$ 1.39B$ 610.00M$ 514.00M$ 428.20M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.07 0.08 0.08 0.10
Debt-to-Equity Ratio
0.07 0.10 0.12 0.12 0.15
Debt-to-Capital Ratio
0.06 0.09 0.11 0.11 0.13
Long-Term Debt-to-Capital Ratio
0.06 0.08 0.09 0.09 0.12
Financial Leverage Ratio
1.30 1.41 1.43 1.46 1.58
Debt Service Coverage Ratio
54.74 89.14 38.36 38.52 22.81
Interest Coverage Ratio
0.00 87.16 91.07 73.29 103.06
Debt to Market Cap
0.01 0.01 0.01 <0.01 0.01
Interest Debt Per Share
1.20 1.17 1.15 1.14 1.14
Net Debt to EBITDA
-1.55 -0.25 -0.04 -0.09 -0.45
Profitability Margins
Gross Profit Margin
78.25%77.02%79.93%76.13%75.36%
EBIT Margin
26.95%26.91%33.32%33.00%21.41%
EBITDA Margin
28.94%29.44%36.42%36.12%24.49%
Operating Profit Margin
26.57%25.55%32.49%25.77%37.12%
Pretax Profit Margin
26.73%26.61%32.84%32.53%20.90%
Net Profit Margin
23.19%23.35%28.28%28.73%18.77%
Continuous Operations Profit Margin
22.72%23.30%28.28%28.73%18.77%
Net Income Per EBT
86.77%87.75%86.11%88.31%89.82%
EBT Per EBIT
100.59%104.17%101.08%126.21%56.29%
Return on Assets (ROA)
10.12%14.98%18.35%17.68%11.38%
Return on Equity (ROE)
13.57%21.09%26.21%25.76%18.00%
Return on Capital Employed (ROCE)
11.96%18.78%24.05%18.05%25.67%
Return on Invested Capital (ROIC)
10.12%16.40%20.57%15.83%22.86%
Return on Tangible Assets
12.95%18.26%22.24%21.44%14.36%
Earnings Yield
2.81%3.03%3.30%1.86%1.45%
Efficiency Ratios
Receivables Turnover
6.59 7.25 7.70 7.87 7.28
Payables Turnover
7.77 6.85 5.35 6.11 5.50
Inventory Turnover
1.12 1.18 1.23 1.72 1.35
Fixed Asset Turnover
3.20 3.26 3.12 3.19 2.95
Asset Turnover
0.44 0.64 0.65 0.62 0.61
Working Capital Turnover Ratio
1.18 2.44 2.55 2.41 2.05
Cash Conversion Cycle
334.98 306.08 274.98 199.00 254.79
Days of Sales Outstanding
55.99 50.34 47.41 46.38 50.16
Days of Inventory Outstanding
325.16 309.03 295.78 212.38 271.00
Days of Payables Outstanding
46.17 53.28 68.21 59.77 66.37
Operating Cycle
381.15 359.36 343.19 258.76 321.16
Cash Flow Ratios
Operating Cash Flow Per Share
1.74 1.48 1.97 2.78 1.69
Free Cash Flow Per Share
1.38 1.04 1.54 2.25 1.04
CapEx Per Share
0.36 0.44 0.43 0.53 0.65
Free Cash Flow to Operating Cash Flow
0.79 0.70 0.78 0.81 0.61
Dividend Paid and CapEx Coverage Ratio
4.78 3.36 4.60 5.25 2.59
Capital Expenditure Coverage Ratio
4.78 3.36 4.60 5.25 2.59
Operating Cash Flow Coverage Ratio
1.45 1.29 1.76 2.51 1.52
Operating Cash Flow to Sales Ratio
0.17 0.15 0.23 0.33 0.24
Free Cash Flow Yield
1.25%1.36%2.06%1.74%1.14%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
35.50 32.99 30.35 53.72 68.98
Price-to-Sales (P/S) Ratio
8.27 7.70 8.58 15.43 12.95
Price-to-Book (P/B) Ratio
4.75 6.96 7.95 13.84 12.42
Price-to-Free Cash Flow (P/FCF) Ratio
60.48 73.49 48.44 57.58 87.79
Price-to-Operating Cash Flow Ratio
47.64 51.64 37.91 46.62 53.87
Price-to-Earnings Growth (PEG) Ratio
-0.53 -5.41 14.63 0.65 -3.22
Price-to-Fair Value
4.75 6.96 7.95 13.84 12.42
Enterprise Value Multiple
27.40 25.92 23.52 42.63 52.42
Enterprise Value
46.18B 45.81B 46.11B 80.58B 56.31B
EV to EBITDA
27.79 25.92 23.52 42.63 52.42
EV to Sales
7.85 7.63 8.57 15.40 12.84
EV to Free Cash Flow
75.97 72.77 48.36 57.46 87.03
EV to Operating Cash Flow
58.09 51.14 37.85 46.52 53.41
Tangible Book Value Per Share
12.49 8.30 7.04 6.97 4.93
Shareholders’ Equity Per Share
17.45 10.96 9.38 9.36 7.35
Tax and Other Ratios
Effective Tax Rate
0.15 0.12 0.14 0.12 0.10
Revenue Per Share
10.06 9.90 8.70 8.39 7.05
Net Income Per Share
2.33 2.31 2.46 2.41 1.32
Tax Burden
0.87 0.88 0.86 0.88 0.90
Interest Burden
1.27 0.99 0.99 0.99 0.98
Research & Development to Revenue
0.18 0.18 0.18 0.17 0.17
SG&A to Revenue
0.00 0.30 0.29 0.29 0.00
Stock-Based Compensation to Revenue
0.03 0.02 0.02 0.02 0.02
Income Quality
0.19 0.64 0.80 1.15 1.28
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis